Announced Mon, 15 Jun · 19:15 IST
New Company Secretary appointed, previous one resigns
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.6%1-day move
₹31.10
prior close
₹31.57
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.0-1.9-1.8-1.9+0.6-0.7-2.3-4.2-5.9-4.8+8.7+8.3——
Up moveDown movePending
AI summary
Shukra Pharmaceuticals' board, at its June 15, 2026 meeting, appointed Mr. Shivkant Dhakad (ACS: A80894) as the new Company Secretary & Compliance Officer. He has 1.5 years of experience as an Assistant Company Secretary. The board also accepted the resignation of Ms. Arpita Kabra (A50258) from the same post, effective the same day, citing personal reasons and other professional commitments. The transition was immediate with no gap.
Likely market impact
Routine KMP transition with immediate replacement. Resignation is for personal reasons, not governance red flags. Minimal impact expected on stock or operations.